Portal Vein Stenting Combined with (125)I Particle Chain Implantation Followed by As(2)O(3) in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumour Thrombus

OBJECTIVE: To evaluate the feasibility and safety of portal vein stenting (PVS) combined with (125)I particle chain implantation and sequential arsenic trioxide (As(2)O(3)) for the treatment of hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT) by transcatheter arterial chemoembo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Res Int
Autors principals: Li, Zhaonan, Si, Guangyan, Jiao, De-Chao, Han, Xinwei, Zhang, Wenguang, Li, Yahua, Zhou, Xueliang, Liu, Juanfang, Chen, Jianjian
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7013352/
https://ncbi.nlm.nih.gov/pubmed/32090088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4109216
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars